HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION
Clinical trials for HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for heart failure patients with kidney disease?
Disease control Recruiting nowThis study tests a drug called eplerenone in 40 people who have both heart failure with reduced pumping function and severe chronic kidney disease. The goal is to see if the drug is safe and feasible for this group, who have been left out of previous studies. If successful, it co…
Matched conditions: HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: PHASE2 • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
Blood clues may predict who benefits from heart rehab
Knowledge-focused Recruiting nowThis study looks at 62 people with heart failure to understand why some get better with exercise rehab while others don't. Researchers will measure oxygen use during exercise and check tiny blood molecules called microRNAs. The goal is to find markers that could help personalize …
Matched conditions: HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION
Sponsor: Centre Hospitalier de Corbie • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC